Search results for "Fertility Agent"

showing 5 items of 15 documents

A high oocyte yield for intracytoplasmic sperm injection treatment is associated with an increased chromosome error rate.

2009

Objective To compare the chromosome error rate among oocytes from stimulated ovaries after retrieval of 1–5 oocytes, 6–10 oocytes, and >10 oocytes. Design Retrospective cohort study. Setting A university-based human genetic institute in collaboration with a private fertility center. Patient(s) Nine hundred thirty-three women undergoing intracytoplasmic sperm injection (ICSI) with a poor prognosis. Intervention(s) Oocyte collection with ovarian stimulation. Polar body testing of ICSI oocytes for common chromosome errors. Main Outcome Measure(s) Chromosome error rate in oocytes, as determined by five-color fluorescence in situ hybridization. Result(s) In women less than 35 years and women bet…

Adultmedicine.medical_specialtymedicine.medical_treatmentmedia_common.quotation_subjectOocyte RetrievalFertilityBiologyIntracytoplasmic sperm injectionAndrologyCohort StudiesPolar bodyOvulation InductionPregnancymedicineHumansSperm Injections IntracytoplasmicIn Situ Hybridization Fluorescencemedia_commonRetrospective StudiesGynecologyChromosome AberrationsPregnancymedicine.diagnostic_testObstetrics and GynecologyChromosomeRetrospective cohort studyFertility Agents FemaleOocytemedicine.diseasemedicine.anatomical_structureTreatment OutcomeReproductive MedicineFemaleFluorescence in situ hybridizationMaternal AgeFertility and sterility
researchProduct

Adjuncts for ovarian stimulation: when do we adopt “orphan indications” for approved drugs?

2009

Several drugs, shown to be safe for other uses, have proven to be highly effective adjuncts for ovarian stimulation. The authors evaluate these "orphan" indications and make recommendations so that more patients will benefit from their use.

Drugendocrine systemmedicine.medical_specialtyOrphan Drug ProductionResearch methodologymedia_common.quotation_subjectFertilization in VitroReproductive technologyAcide acétylsalicyliqueHealth servicesProstaglandin-Endoperoxide SynthaseOvulation InductionHumansMedicineIntensive care medicinemedia_commonGynecologyAspirinHuman Growth Hormonebusiness.industryObstetrics and GynecologyErgot DerivativesEstrogensMetforminReproductive MedicineDopamine AgonistsAndrogensFemaleFertility agentsLeuprolidebusinessContraceptives OralPolycystic Ovary SyndromeFertility and Sterility
researchProduct

The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study

2013

OBJECTIVE: To explore if the GnRH analogue used for controlled ovarian stimulation (COS) and the ovulation triggering factor (GnRH agonist + hCG triggering versus GnRH antagonist + GnRH agonist triggering) affect embryo development and kinetics.STUDY DESIGN: In a retrospective cohort study in the Instituto Valenciano de Infertilidad (IVI) Alicante and the Instituto Universitario-IVI Valencia, Spain, 2817 embryos deriving from 400 couples undergoing oocyte donation were analysed. After controlled ovarian stimulation and IVF/intracytoplamic sperm injection, the timing of embryonic cleavages was assessed by a video time-lapse system. The results were analysed using Student's t test for compari…

Pregnancy RateZygoteGonadotropin-Releasing Hormone/adverse effectsmedicine.medical_treatmentGonadotropin-releasing hormoneChorionic GonadotropinGonadotropin-Releasing HormoneEmbryo Culture TechniquesCohort StudiesTime-lapsePregnancyGnRH analogueFertility Agents Female/adverse effectsmedia_commonOocyte DonationObstetrics and GynecologyEmbryoEmbryo transferembryonic structuresSpain/epidemiologyEctogenesis/drug effectsFemaleInfertility Femalehormones hormone substitutes and hormone antagonistsEmbryo qualityAdultAgonistInfertility Female/therapyendocrine systemmedicine.medical_specialtymedicine.drug_classCleavage Stage Ovummedia_common.quotation_subjectFertilization in VitroBiologyTime-Lapse ImagingOvulation InductionInternal medicinemedicineHumansOvulationRetrospective StudiesZygote/drug effectsFertility Agents FemaleOvulation Induction/methodsEmbryo TransferEmbryo developmental kineticsKineticsPregnancy rateEndocrinologyReproductive MedicineSpainEctogenesisChorionic Gonadotropin/pharmacologyOvulation inductionCleavage Stage Ovum/drug effectsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Physiology and Pathology of Ovarian Hyperstimulation Syndrome

2010

Ovarian hyperstimulation syndrome (OHSS) occurs when ovaries primed with follicle-stimulating hormone/leuteinizing hormone (LH) are subsequently exposed to human chorionic gonadotropin (hCG). The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). With the administration of hCG, the expression vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases significantly rising to a maximum coinciding with peaked VP. Immunohistochemistry shows the presence of VEGF and VEGFR-2 proteins in the granulosa-lutein and endothelial cells of the entire corpus luteum. These findings suggest that the syndrome can be prevented…

Vascular Endothelial Growth Factor AAgonistendocrine systemmedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismOvarian hyperstimulation syndromeBiologyModels BiologicalDopamine agonistHuman chorionic gonadotropinOvarian Hyperstimulation SyndromeEndocrinologyOvulation InductionPregnancyPhysiology (medical)Internal medicineCabergolinemedicineAnimalsHumansLeuteinizing hormoneQuinagolideObstetrics and GynecologyFertility Agents Femalemedicine.diseaseVascular Endothelial Growth Factor Receptor-2medicine.anatomical_structureEndocrinologyReproductive MedicineDopamine AgonistsFemaleCorpus luteummedicine.drugSeminars in Reproductive Medicine
researchProduct

Clinical factors affecting endometrial receptiveness in oocyte donation cycles.

2008

Objective To provide a summary of the actual knowledge about the clinical factors affecting the oocyte recipient (other than those associated with uterine cavity abnormalities) on the outcome of oocyte donation cycles. Design Review of the literature. Setting Information regarding the association between age, body mass index (BMI), endometrial priming, tobacco consumption, hydrosalpinx, and endometriosis/adenomyosis in oocyte recipients and the results of oocyte donation cycles. Result(s) Recipient age and the presence of hydrosalpinx are clearly associated with a poorer outcome in oocyte donation cycles. The negative impact of tobacco consumption has recently been confirmed. The exact rele…

medicine.medical_specialtyEndometriosisEndometriosisEndometriumBody Mass IndexEndometriumPregnancyMedicineHumansAdenomyosisEmbryo ImplantationHydrosalpinxGynecologyPregnancyOocyte Donationbusiness.industrySmokingAge FactorsPregnancy OutcomeObstetrics and GynecologyFertility Agents FemaleFallopian Tube Diseasesmedicine.diseaseOocytemedicine.anatomical_structureReproductive MedicineFemaleUterine cavitybusinessBody mass indexFertility and sterility
researchProduct